Description
Walrycin B inhibits the walrycin response regulator (WalR). This compound exhibits antibacterial activity, altering cell wall metabolism and cell division in Bacillus and Staphylococcus.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Walrycin B inhibits the walrycin response regulator (WalR). This compound exhibits antibacterial activity, altering cell wall metabolism and cell division in Bacillus and Staphylococcus.
| Cas No. | 878419-78-4 |
|---|---|
| Purity | ≥98% |
| Formula | C14H10F3N5O2 |
| Formula Wt. | 337.26 |
| IUPAC Name | 1,6-Dimethyl-3-[4-(trifluoromethyl)phenyl]pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione |
| Solubility | DMSO: 11.5 mg/mL |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Gotoh Y, Doi A, Furuta E, et al. Novel antibacterial compounds specifically targeting the essential WalR response regulator. J Antibiot (Tokyo). 2010 Mar;63(3):127-34. PMID: 20111065.
Immunomodulator; teratogen.
Thio sulforaphane analog, ITC.
Purine nucleotide analog, mercaptiopurine prodr...
CDK2 inhibitor.
Protease inhibitor.
Inhibitor of VEGFR1/2/3.
TGR5 agonist.
PDEδ inhibitor.
α1-adrenergic antagonist.
Optically active isomer of ibuprofen, NSAID; CO...
L-type Ca2+ channel blocker.
ASK1 inhibitor.
Antibacterial (Antimyobacterial) agent.
Sesquiterpene lactone derived from Artemesia.
mTOR inhibitor.
Synthetic vitamin E, antioxidant.
RXR agonist.
ALK4/5/7 (activin-like) inhibitor, TGF-β inhib...
MAGL inhibitor.
Benzimidazole; microtubule polymerization inhib...